EE+ POEM Archive
Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists
Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Older Patients With Atrial Fibrillation Treated With DOACs Have Fewer Strokes and Systemic Emboli Than Those Treated With Vitamin K Antagonists." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315793/all/Older_patients_with_atrial_fibrillation_treated_with_DOACs_have_fewer_strokes_and_systemic_emboli_than_those_treated_with_vitamin_K_antagonists.
Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315793/all/Older_patients_with_atrial_fibrillation_treated_with_DOACs_have_fewer_strokes_and_systemic_emboli_than_those_treated_with_vitamin_K_antagonists. Accessed March 29, 2023.
Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315793/all/Older_patients_with_atrial_fibrillation_treated_with_DOACs_have_fewer_strokes_and_systemic_emboli_than_those_treated_with_vitamin_K_antagonists
Older Patients With Atrial Fibrillation Treated With DOACs Have Fewer Strokes and Systemic Emboli Than Those Treated With Vitamin K Antagonists [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315793/all/Older_patients_with_atrial_fibrillation_treated_with_DOACs_have_fewer_strokes_and_systemic_emboli_than_those_treated_with_vitamin_K_antagonists.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists
ID - 1315793
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315793/all/Older_patients_with_atrial_fibrillation_treated_with_DOACs_have_fewer_strokes_and_systemic_emboli_than_those_treated_with_vitamin_K_antagonists
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
